Related Experiment Video
Updated: Aug 24, 2025

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Druggable targets and therapeutic development for COVID-19
Xiaohua Duan1, Lauretta A Lacko1, Shuibing Chen1
1Department of Surgery, Weill Cornell Medicine, New York, NY, United States.
This study explores therapeutic targets for COVID-19 by examining SARS-CoV-2 proteins and host factors. It reviews current and investigational treatments for coronavirus disease.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Coronavirus disease (COVID-19), caused by SARS-CoV-2, presents significant global health and economic challenges.
- Limited therapeutic options necessitate deeper understanding of viral biology and host interactions.
- SARS-CoV-2 proteins are crucial for its life cycle, making them potential drug targets.
Purpose of the Study:
- To discuss the medicinal value of essential SARS-CoV-2 proteins and key host factors.
- To review current therapeutic interventions for COVID-19 patients.
- To highlight potential targets for novel COVID-19 treatments.
Main Methods:
- Review of scientific literature on SARS-CoV-2 proteins and host interactions.
- Analysis of viral life cycle mechanisms.
- Summary of clinical trial data for COVID-19 therapeutics.
Main Results:
- SARS-CoV-2 proteins and host factors are identified as critical for viral replication and pathogenesis.
- A range of therapeutic strategies targeting viral and host components are under investigation.
- Approved and experimental treatments show varying efficacy.
Conclusions:
- Targeting SARS-CoV-2 proteins and host factors offers promising avenues for COVID-19 treatment.
- Continued research into viral-host interactions is vital for developing effective therapies.
- Comprehensive review of interventions aids clinical decision-making and future drug development.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...